45865-0563
Ondansetron
Ondansetron
TABLET, ORALLY DISINTEGRATING
Oral
Ondansetron
8.0
mg/1
45865-0563-10
10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (45865-563-10)
Sept. 1, 2015

45865-0563-30
30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (45865-563-30)
Sept. 1, 2015
Ancillary Therapy
Antiemetic
5HT3 Receptor Antagonist
 
In Use